1. Home
  2. VTVT vs BODI Comparison

VTVT vs BODI Comparison

Compare VTVT & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTVT
  • BODI
  • Stock Information
  • Founded
  • VTVT 2015
  • BODI 1998
  • Country
  • VTVT United States
  • BODI United States
  • Employees
  • VTVT N/A
  • BODI N/A
  • Industry
  • VTVT Biotechnology: Pharmaceutical Preparations
  • BODI Industrial Machinery/Components
  • Sector
  • VTVT Health Care
  • BODI Industrials
  • Exchange
  • VTVT Nasdaq
  • BODI Nasdaq
  • Market Cap
  • VTVT 54.4M
  • BODI 46.9M
  • IPO Year
  • VTVT 2015
  • BODI N/A
  • Fundamental
  • Price
  • VTVT $20.89
  • BODI $5.11
  • Analyst Decision
  • VTVT Strong Buy
  • BODI Buy
  • Analyst Count
  • VTVT 2
  • BODI 2
  • Target Price
  • VTVT $35.50
  • BODI $10.00
  • AVG Volume (30 Days)
  • VTVT 4.2K
  • BODI 14.8K
  • Earning Date
  • VTVT 11-12-2025
  • BODI 11-07-2025
  • Dividend Yield
  • VTVT N/A
  • BODI N/A
  • EPS Growth
  • VTVT N/A
  • BODI N/A
  • EPS
  • VTVT N/A
  • BODI N/A
  • Revenue
  • VTVT $17,000.00
  • BODI $324,871,000.00
  • Revenue This Year
  • VTVT N/A
  • BODI N/A
  • Revenue Next Year
  • VTVT N/A
  • BODI N/A
  • P/E Ratio
  • VTVT N/A
  • BODI N/A
  • Revenue Growth
  • VTVT N/A
  • BODI N/A
  • 52 Week Low
  • VTVT $12.62
  • BODI $3.38
  • 52 Week High
  • VTVT $26.99
  • BODI $8.71
  • Technical
  • Relative Strength Index (RSI)
  • VTVT 48.86
  • BODI 41.06
  • Support Level
  • VTVT $20.19
  • BODI $4.75
  • Resistance Level
  • VTVT $21.20
  • BODI $5.76
  • Average True Range (ATR)
  • VTVT 0.97
  • BODI 0.42
  • MACD
  • VTVT -0.30
  • BODI -0.05
  • Stochastic Oscillator
  • VTVT 33.54
  • BODI 34.29

About VTVT vTv Therapeutics Inc.

vTv Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of cadisegliatin, a novel, potential first-in-class oral adjunctive therapy to insulin, being investigated for the treatment of type 1 diabetes (T1D). Its product pipeline includes TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.

About BODI The Beachbody Company Inc. Class A Common Stock

The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.

Share on Social Networks: